Coronavirus patients can benefit from blood of the recovered, new study shows
4 years, 9 months ago

Coronavirus patients can benefit from blood of the recovered, new study shows

LA Times  

For 10 patients severely ill with the new coronavirus, a single dose of antibodies drawn from the blood of people who had recovered from COVID-19 appeared to save lives, shorten the duration of symptoms, improve oxygen levels and speed up viral clearance, newly published research reports. Armed with a veteran infectee’s immune memory of the virus, patients getting convalescent plasma appeared to recover more quickly and completely than patients who did not get the treatment, physicians observed. “This pilot study on therapy shows a potential therapeutic effect and low risk in the treatment of severe COVID-19 patients,” the authors of the new research wrote. In recent days, the New York Blood Center has issued an urgent appeal for recovered COVID-19 patients to donate blood plasma for the creation of antibody-rich infusions.

Patients Blood Symptoms Study His Lungs Plasma Recovered Convalescent Plasma Convalescent  study  convalescent  covid19  plasma  patients  blood  coronavirus  recovered  shows  therapy  day  benefit  symptoms

History of this topic

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans
1 year, 11 months ago

FDA revokes authorization for key anti-COVID drug, a blow for vulnerable Americans

LA Times  

A two-shot dose of Evusheld at a University of Washington Medicine clinic in Seattle. For her patients, she said, “it was kind of like being told the seat belts in your car won’t work anymore, and we’re not going to be able to replace them with anything.” In recent months, nine new subvariants of the dominant Omicron strain have proven …

Covid-19 vaccine protects patients with blood cancer: Study
2 years ago

Covid-19 vaccine protects patients with blood cancer: Study

Hindustan Times  

People with blood cancer usually have a weak immune system, putting them at an increased risk of becoming very ill from Covid-19. Covid-19 vaccine protects patients with blood cancer: Study A team led by physicians Dr. Andrea Keppler-Hafkemeyer and Dr. Christine Greil from the Medical Center-University of Freiburgand virologist Prof. Oliver T. Keppler from LMU Munich has now characterized in …

World Blood Donor Day 2022: Importance of Blood Donation During COVID-19 Pandemic
2 years, 6 months ago

World Blood Donor Day 2022: Importance of Blood Donation During COVID-19 Pandemic

News 18  

World Blood Donor Day is observed on June 14 to raise awareness about the importance of blood donation as the range of applications is far greater than most people realise. For this year, the World Blood Donor Day slogan is “Donating blood is an act of solidarity. Much like with newly emerging infectious diseases of the past, people have been …

Coronavirus antibodies in donated blood halves in two months
3 years ago

Coronavirus antibodies in donated blood halves in two months

Dutch News  

The amount of antibodies against coronavirus found in blood given by vaccinated blood donors has halved in two months, according to donation agency Sanquin. The longer ago people were vaccinated, the fewer antibodies they have, Sanquin said, following research on blood donated by 2,200 people. ‘Antibodies for respiratory infections usually decrease quickly over time,’ said microbiologist and researcher Hans Zaaijer. …

Coronavirus antibodies in donated blood halves in two months
3 years ago

Coronavirus antibodies in donated blood halves in two months

Dutch News  

The amount of antibodies against coronavirus found in blood given by vaccinated blood donors has halved in two months, according to donation agency Sanquin. The longer ago people were vaccinated, the fewer antibodies they have, Sanquin said, following research on blood donated by 2,200 people. ‘Antibodies for respiratory infections usually decrease quickly over time,’ said microbiologist and researcher Hans Zaaijer. …

Curing with Blood: the Rise and Fall of Covid Convalescent Plasma Therapy
3 years, 3 months ago

Curing with Blood: the Rise and Fall of Covid Convalescent Plasma Therapy

News 18  

Early in the pandemic, scientists thought convalescent plasma might be a way to treat COVID-19. But growing evidence, including an international study published this week, shows convalescent plasma does not save lives of people critically ill with COVID-19. year more than 100 clinical trials had been conducted with convalescent plasma in people with COVID-19; about one-third of these studies had …

Use of plasma therapy for Covid may cause adverse events: Study
3 years, 3 months ago

Use of plasma therapy for Covid may cause adverse events: Study

Hindustan Times  

Even with doubtful efficacy, antibody-rich plasma from recovered Covid-19 patients continued to be used for the treatment of those suffering from the infection during the second wave of the pandemic, with people queuing up at plasma banks and looking for donors online. But a recent Canadian study published in the journal Nature has shown that not only did plasma therapy …

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’
3 years, 4 months ago

Regeneron: Covid-19 antibody treatments work, but they’re ‘not the path out of this pandemic’

CNN  

CNN — When Texas Gov. Monoclonal antibodies such as those made by Regeneron and GlaxoSmithKline won’t work for every Covid-19 patient; mAbs, as they are known, are only available for people age 12 and older and who aren’t hospitalized or severely ill. Regeneron’s therapy can also be used for some people who know they were exposed to the virus,but don’t …

Patients unable to produce Covid antibodies supported by new drug
3 years, 5 months ago

Patients unable to produce Covid antibodies supported by new drug

NL Times  

The Erasmus Medical Center has begun using the drug REGEN-Cov to treat patients with Covid-19 who have a reduced ability to produce antibodies themselves. “You are buying time for patients to make their own antibodies”, said Bart Rijnders, an internist and infectious diseases specialist at the hospital. “In patients who will never produce their own antibodies, it helps the other …

UK trial scores another win against Covid as study shows benefit of antibody treatment in sickest patients
3 years, 6 months ago

UK trial scores another win against Covid as study shows benefit of antibody treatment in sickest patients

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Giving patients who have yet to develop an immune response to the virus an infusion …

Body produces antibodies against COVID-19 for months even after a mild infection: Study
3 years, 7 months ago

Body produces antibodies against COVID-19 for months even after a mild infection: Study

Firstpost  

In the bone marrow, these cells continually secrete low levels of antibodies into the bloodstream to help guard against the virus. It’s normal for antibody levels to go down after acute infection, but they don’t go down to zero; they plateau.” The researchers found antibody-producing cells in people 11 months after first symptoms. In the bone marrow, these cells continually …

Does India's trial and error approach to fighting mutating coronavirus need course correction?
3 years, 7 months ago

Does India's trial and error approach to fighting mutating coronavirus need course correction?

India Today  

The second wave continues to wreak havoc in India with over 4,500 deaths recorded in a day on Wednesday. The Indian Council of Medical Research decision came within days of a study published in The Lancet that suggested plasma therapy did not improve survival or other pre-specified clinical outcomes in patients. Interestingly, similar data from ICMR's own trials was released …

Top medical experts welcome move to remove plasma therapy from COVID-19 treatment
3 years, 7 months ago

Top medical experts welcome move to remove plasma therapy from COVID-19 treatment

Deccan Chronicle  

New Delhi: Several top medical experts have welcomed the Indian Council of Medical Research 's updated advisory released on Monday dropping the use of convalescent plasma from recommended treatment protocols for COVID-19. Sir Ganga Ram Hospital chairman Dr DS Rana said plasma therapy has failed to change the "course of mortality" and asserted that some scientists are also of the …

Not enough evidence to prove plasma therapy works: Top ICMR scientist on why India changed treatment protocol
3 years, 7 months ago

Not enough evidence to prove plasma therapy works: Top ICMR scientist on why India changed treatment protocol

India Today  

The Centre on Monday revised the clinical guidance for Covid-19 treatment, dropping the off-label use of convalescent plasma from the treatment protocol for adult patients. Dr Samiran Panda, Indian Council of Medical Research scientist who was also a part of the panel that dropped plasma therapy from Covid-19 management guidelines, told India Today that the decision was taken since anecdotal …

Why government has dropped plasma therapy for Covid-19
3 years, 7 months ago

Why government has dropped plasma therapy for Covid-19

India Today  

India has officially removed the use of convalescent plasma, popularly known as the plasma therapy, on Covid-19 patients from its clinical management guidelines for the disease. The previous guidelines allowed “off label” use of plasma therapy on Covid-19 patients during moderate stage within seven days of the onset of symptoms. WHY GOVERNMENT DROPPED PLASMA THERAPY Many a time, the prescription …

Found Ineffective, Plasma Therapy No Longer Recommended For Covid-19 Treatment
3 years, 7 months ago

Found Ineffective, Plasma Therapy No Longer Recommended For Covid-19 Treatment

News 18  

Days after various studies and expert panels suggested that plasma therapy on Covid-19 patients was found ineffective in reducing the progression to severe disease or death, the treatment protocol has been dropped from the clinical management guidelines, sources said. In the letter, which was also marked to ICMR chief Balram Bhargava and AIIMS Director Randeep Guleria, public health professionals alleged …

Govt removes plasma therapy as treatment for Covid-19 among adults
3 years, 7 months ago

Govt removes plasma therapy as treatment for Covid-19 among adults

India Today  

A government-appointed task force on Covid-19 on Monday removed plasma therapy from the treatment protocol for adult Covid-19 patients. In the revised clinical guidelines for management of adult Covid-19 patients, use of convalescent plasma therapy has been removed even as an 'off label treatment. Until now, India's Covid-19 treatment protocol allowed 'off label' use of convalescent plasma therapy but only …

COVID-19: Plasma therapy not found effective, likely to be dropped from clinical management guidelines
3 years, 7 months ago

COVID-19: Plasma therapy not found effective, likely to be dropped from clinical management guidelines

Firstpost  

The present guidelines allows ‘off label’ use of plasma therapy at the stage of early moderate disease, that is, within seven days of the onset of symptoms New Delhi: Plasma therapy on COVID-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped from the clinical management guidelines, sources …

Plasma therapy not effective, likely to be dropped from clinical management guidelines on Covid-19
3 years, 7 months ago

Plasma therapy not effective, likely to be dropped from clinical management guidelines on Covid-19

India Today  

Plasma therapy on Covid-19 patients has not been found effective in reducing the progression to severe disease or death and is likely to be dropped from the clinical management guidelines, sources said. In the letter, which was also marked to ICMR chief Balram Bhargava and AIIMS Director Randeep Guleria, public health professionals alleged that the current guidelines on plasma therapy …

Coronavirus breakthrough in Amsterdam could reduce ICU admissions
3 years, 7 months ago

Coronavirus breakthrough in Amsterdam could reduce ICU admissions

Dutch News  

Scientists in Amsterdam say they have solved one of the most vexing puzzles of Covid-19: why some patients deteriorate rapidly just as the virus seems to be on the wane. The team at the UMC teaching hospital found that while the majority of hospital patients recover, a few produce excessive numbers of antibodies, causing potentially fatal inflammation of the lungs. …

Coronavirus breakthrough in Amsterdam could reduce ICU admissions
3 years, 7 months ago

Coronavirus breakthrough in Amsterdam could reduce ICU admissions

Dutch News  

Scientists in Amsterdam say they have solved one of the most vexing puzzles of Covid-19: why some patients deteriorate rapidly just as the virus seems to be on the wane. The team at the UMC teaching hospital found that while the majority of hospital patients recover, a few produce excessive numbers of antibodies, causing potentially fatal inflammation of the lungs. …

Stop irrational use of plasma, may develop more virulent strains of Covid, warn experts
3 years, 7 months ago

Stop irrational use of plasma, may develop more virulent strains of Covid, warn experts

India Today  

A group of doctors, public health officials and experts have written to the Centre’s principal scientific advisor along with the AIIMS chief and ICMR chief, raising concerns over the “irrational and non-scientific use of convalescent plasma for Covid-19”. The letter addressed to Principal Scientific Advisor Dr Vijay Raghavan says, “We are writing to you as concerned clinicians, public health professionals …

COVID treatment has improved, but many wish for an easy pill
3 years, 8 months ago

COVID treatment has improved, but many wish for an easy pill

Associated Press  

If Priscila Medina had gotten COVID-19 a year ago, she would have had no treatments proven safe and effective to try. serious disease requiring hospitalization, and occasionally even tragic deaths,” the U.S. government’s top infectious disease expert, Dr. Anthony Fauci, recently told the National Press Club. Remdesivir also is the only antiviral COVID-19 medicine — it interferes with virus reproduction …

COVID treatment has improved, but many wish for an easy pill
3 years, 8 months ago

COVID treatment has improved, but many wish for an easy pill

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. serious disease requiring hospitalization, and …

Fact Check: Old list of blood donors circulated as plasma donors for Covid patients
3 years, 8 months ago

Fact Check: Old list of blood donors circulated as plasma donors for Covid patients

India Today  

As India is battling a renewed surge in Covid-19 cases, several states are witnessing a shortage of plasma from recovered patients. In 2016, a Facebook page named BLOOD DONORS shared the same list as from Andhra Pradesh and Telangana. Even in 2020, after the Covid-19 pandemic broke out in India, the same list had gone viral, claiming to be of …

Convalescent Plasma Strikes Out As COVID-19 Treatment
3 years, 10 months ago

Convalescent Plasma Strikes Out As COVID-19 Treatment

NPR  

Convalescent Plasma Strikes Out As COVID-19 Treatment Enlarge this image toggle caption Karen Ducey/Getty Images Karen Ducey/Getty Images More than half a million Americans have received an experimental treatment for COVID-19 called convalescent plasma. Sponsor Message She recalls thinking, "we have this new disease that didn't have any known therapies, and convalescent plasma has been used in new epidemic and …

Study shows Covid-19 evolved during treatment, convalescent plasma therapy patients had UK mutant
3 years, 11 months ago

Study shows Covid-19 evolved during treatment, convalescent plasma therapy patients had UK mutant

India Today  

A recent study has revealed that the dominant variant of the novel coronavirus or Covid-19 that emerged in patients after the convalescent plasma therapy possessed a mutation that is also present in the one first discovered in the UK. ".data reveal strong selection on SARS-CoV-2 during convalescent plasma therapy associated with the emergence of viral variants with evidence of reduced …

Worrying new coronavirus variants could be home grown as well as imported
3 years, 11 months ago

Worrying new coronavirus variants could be home grown as well as imported

CNN  

CNN — The 45-year-old patient had been sick with coronavirus for months. “This patient’s mutations include hallmarks of the new variants, like N501Y and 484K,” Li said. Then, as we saw these new variants emerging from the UK, from South Africa, from Brazil, we saw the same mutations.” The case, which Li and colleagues detailed late last year in a …

Covid research: Convalescent plasma trial paused as results poor
3 years, 11 months ago

Covid research: Convalescent plasma trial paused as results poor

Daily Mail  

Injecting critically ill coronavirus patients with the blood of survivors does not boost their chances of getting better, a major study has found. Scientists running the REMAP-CAP trial have stopped enrolling infected ICU patients after finding 'no evidence' convalescent plasma therapy boosted survival rates. Health Secretary Matt Hancock donated his blood after recovering from coronavirus in March A clinical trial …

Studies find having COVID-19 may protect against reinfection
4 years ago

Studies find having COVID-19 may protect against reinfection

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. on the order of the …

Studies find having COVID-19 may protect against reinfection
4 years ago

Studies find having COVID-19 may protect against reinfection

Associated Press  

Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. on the order of the same kind of protection you’d get from an effective vaccine,” of getting the virus again, said Dr. Ned Sharpless, director of the U.S. National Cancer Institute. Among the 1,265 who had coronavirus antibodies at the outset, only two had …

Recovered Covid-19 patients last immunity for 8 months, raise hopes for vaccine: Study
4 years ago

Recovered Covid-19 patients last immunity for 8 months, raise hopes for vaccine: Study

India Today  

People who have recovered from the novel coronavirus infection have immune memory to protect against reinfection for at least eight months, according to a new study that provides strong evidence for the likelihood that Covid-19 vaccines will work for long periods. According to the scientists, including those from Monash University in Australia, specific cells within the immune system called memory …

Coronavirus | ICMR warns against indiscriminate use of convalescent plasma therapy
4 years, 1 month ago

Coronavirus | ICMR warns against indiscriminate use of convalescent plasma therapy

The Hindu  

The Indian Council of Medical Research has warned against indiscriminate use of convalescent plasma therapy for treating COVID-19. On Wednesday, it released report of an open-label phase II multicentre randomised controlled trial conducted across 39 public and private hospitals on the use of CPT in management of cases with moderate infection. The report concluded that the therapy “did not lead …

Indiscriminate Use of Convalescent Plasma Therapy in Covid Patients Not Advisable, Warns ICMR
4 years, 1 month ago

Indiscriminate Use of Convalescent Plasma Therapy in Covid Patients Not Advisable, Warns ICMR

News 18  

The country's apex health research body, ICMR, has issued an advisory statingthat indiscriminate use of convalescent plasma therapy in coronavirus infected patients is not advisable. In an "Evidence Based Advisory to address Inappropriate Use of Convalescent Plasma in COVID-19 Patients", the Indian Council of Medical Research said that a potential donor for convalescent plasma should have sufficient concentration of antibody …

Indiscriminate Use of Plasma Therapy Not Advisable: ICMR
4 years, 1 month ago

Indiscriminate Use of Plasma Therapy Not Advisable: ICMR

The Quint  

Experts in India have long called out the lack of evidence to support this treatment. Speaking to FIT, Dr Sumit Ray, Senior consultant of Critical Care Medicine, Holy Family Hospital, said, “The theoretical benefit of plasma therapy is in helping boost immunity if not enough is developed in the patient. But, the problem with COVID-19 is not of an inadequate …

Dutch Covid medicine made from blood plasma ready for use
4 years, 1 month ago

Dutch Covid medicine made from blood plasma ready for use

NL Times  

Blood bank Sanquin and plasma producer Sanquin Plasma Products produced 4 thousand doses of Covid-19 antibody treatment made from the blood plasma of recovered patients. The plasma medicine will first go towards preventing coronavirus infections in people with weakened immune systems, such as cancer patients and people who have just undergone an organ transplant. Minister Hugo de Jonge of Public …

Treatment Protocols Being Reassessed 10 Months into Covid-19 Pandemic, Focus on Aspirin as Potential Drug
4 years, 2 months ago

Treatment Protocols Being Reassessed 10 Months into Covid-19 Pandemic, Focus on Aspirin as Potential Drug

News 18  

“From today, aspirin will be investigated in the world’s largest clinical trial of treatments for patients hospitalised with COVID-19. The Randomised Evaluation of COVid-19 therapy trial is taking place in 176 hospital sites across the UK, and has so far recruited over 16,000 patients,” read the RECOVERY Trial’s web information page on Aspirin. This is the newest entrant in the …

The plasma dead end?
4 years, 2 months ago

The plasma dead end?

India Today  

Since ILBS Hospital, in New Delhi, inaugurated its plasma bank in early July, requests have poured in ceaselessly. Many examples of adverse reactions and the inability of plasma treatment to reduce Covid mortality have been recorded in the ICMR’s PLACID trial too. As a result, the ICMR has announced the possibility of removing convalescent plasma therapy as one of the …

Plasma Therapy Doesn't Reduce COVID Mortality: ICMR Study in BMJ
4 years, 2 months ago

Plasma Therapy Doesn't Reduce COVID Mortality: ICMR Study in BMJ

The Quint  

In India, the treatment first made news in mid-April when a patient in Delhi received experimental plasma therapy and was weaned off from ventilator support. Delhi’s Max Hospital gave a 49-year-old male COVID-19 patient plasma treatment on compassionate grounds. In the experimental treatment, antibodies from the blood of patients who have recovered from coronavirus are given to those battling the …

’Plasma therapy has saved lives of many including mine’: Jain on ICMR’s decision
4 years, 2 months ago

’Plasma therapy has saved lives of many including mine’: Jain on ICMR’s decision

Live Mint  

Delhi health minister Satyender Jain on Wednesday said that plasma therapy treatment has saved lives of many from the novel coronavirus in the past months, after the Indian Council of Medical Research on Tuesday said that it considers removing it from Covid-19 national treatment protocol. "Lives of more than 2000 people, including mine, have been saved through plasma therapy, so …

ICMR may remove plasma therapy from Covid-19 treatment guidelines
4 years, 2 months ago

ICMR may remove plasma therapy from Covid-19 treatment guidelines

Live Mint  

New Delhi: The government is planning to delete convalescent plasma therapy from the national guidelines for covid-19 treatment after the Indian Council of Medical Research’s clinical trial showed that the therapy did not significantly benefit patients suffering from the disease, ICMR DG Balram Bhargava said on Tuesday. ICMR, which is the government’s apex bio-medical research agency, had conducted a 464 …

Male, elderly patients with severe COVID-19 may have higher levels of antibodies in their plasma, reveals study
4 years, 2 months ago

Male, elderly patients with severe COVID-19 may have higher levels of antibodies in their plasma, reveals study

Firstpost  

Scientists said that a possible explanation for this could be that due to severe disease, the inflammatory response in the body gets accelerated, recruiting more B-cells to fight the infection. This consequently results in more antibody production In the absence of definitive treatment for COVID-19, doctors are working on repurposing drugs to manage symptoms, reduce disease severity and using plasma …

The Rise & Fall of Plasma Therapy as COVID-19 Treatment in India
4 years, 2 months ago

The Rise & Fall of Plasma Therapy as COVID-19 Treatment in India

The Quint  

On a daily basis, one gets at least two to three messages of desperate family members searching for a plasma donor for their loved ones battling COVID-19. Delhi set up a plasma bank in June to cater to the increasing demand of COVID-19 patients, with several states following the example. In June, the Union Health Ministry, in their clinical guidelines …

What are the treatment options for COVID-19?
4 years, 2 months ago

What are the treatment options for COVID-19?

Associated Press  

What are the treatment options for COVID-19? Here’s what’s advised for various patients: -- Not hospitalized or hospitalized but not needing extra oxygen: No specific drugs recommended, and a warning against using steroids. -- Hospitalized and needing extra oxygen but not a breathing machine: The antiviral drug remdesivir, given through an IV, and in some cases also a steroid. However, …

In recovering COVID-19 patients, antibodies fade quickly: Study
4 years, 2 months ago

In recovering COVID-19 patients, antibodies fade quickly: Study

Live Mint  

Antibody levels in the blood of COVID-19 patients drop rapidly during the weeks after their bodies have cleared the novel coronavirus, and symptoms have subsided, according to a study. However, recovering patients can't donate blood until at least 14 days after symptoms have subsided, to give the body time to clear viral particles. "But at the same time, our work …

Coronavirus | Repurposed drugs did not cut down mortality, says WHO
4 years, 2 months ago

Coronavirus | Repurposed drugs did not cut down mortality, says WHO

The Hindu  

Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, have indicated that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalised patients as per information released by the World Health Organisation. Speaking exclusively to The Hindu, about the outcome Prof. K …

Coronavirus antibodies from blood plasma donations start to fade three months after symptoms start
4 years, 3 months ago

Coronavirus antibodies from blood plasma donations start to fade three months after symptoms start

Daily Mail  

Coronavirus antibodies in blood plasma donations fade rapidly after symptoms first appear, a new study suggests. Researchers followed a small group of recovered COVID-19 patients who donated their blood and found all of them showed decreases in antibodies after three months. Convalescent plasma therapy is when the liquid portion of blood is taken from a recovered COVID-19 patients and transferred …

Covid-19: Plasma therapy to start in eight north Bengal districts
4 years, 3 months ago

Covid-19: Plasma therapy to start in eight north Bengal districts

Hindustan Times  

The West Bengal government will start plasma therapy for coronavirus disease patients in eight districts in north Bengal next week. Indian Council of Medical Research has allowed convalescent plasma to be used for moderately ill Covid-19 patients. Convalescent plasma therapy involves extraction of plasma from the blood of Covid-19 patients four weeks after they have been cured of their viral …

Delhi to Continue Plasma Therapy for Coronavirus Patients Despite ICMR Study Showing No Benefit
4 years, 4 months ago

Delhi to Continue Plasma Therapy for Coronavirus Patients Despite ICMR Study Showing No Benefit

News 18  

Covid-19 patients in national capital will continue to be treated with blood plasma donated by survivors of the novel coronavirus, Delhi’s health minister Satyendar Jain said on Thursday despite clinical trials not proving whether plasma therapy can help people fighting the infection. A trial conducted across 39 hospitals in India and spearheaded by the Indian Council of Medical Research found …

Coronavirus | Plasma therapy didn’t help COVID-19 patients: ICMR
4 years, 4 months ago

Coronavirus | Plasma therapy didn’t help COVID-19 patients: ICMR

The Hindu  

Convalescent plasma therapy failed to benefit coronavirus patients, the largest trial conducted across 39 hospitals in India and spearheaded by the Indian Council of Medical Research found. The trial spanning April-July enrolled 464 hospitalised patients with “moderate” COVID-19 and administered convalescent plasma — antibodies derived from plasma filtered from the blood of those who have recovered from COVID-19 — on …

Discover Related